How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AP

NASDAQ:APLT
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AP

Applied Therapeutics IncNASDAQ APLT Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is APLT undervalued compared to its fair value?

The fair value of APLT stock is hidden USD. Relative to the market price of 5.14 USD Applied Therapeutics Inc is hidden.

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. The company is headquartered in New York City, New York and currently employs 34 ...[More about valuation]

Applied Therapeutics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.601 $B

Price:

5.14 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.67

FINANCIALS

Applied Therapeutics financial for reporting period

Income Statement

0.0002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.021 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.084 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0002 B 100%
-0.021 B -11102%
-0.084 B -44178%

Balance Sheet

0.15 B
0.067 B

Financial Position Analysis

Assets

0.15 B
Current Assets
0.15 B
Total non-current assets
0.0003 B

Total current liabilities
0.084 B
Total non-current liabilities
0 B

Cash Flow Statement

-0.019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Applied Therapeutics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-3164 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-374 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is APLT attractive for investment based on fundamental analysis?

APLT stock rating is hidden. Applied Therapeutics is a hidden by Eyestock methodology.

Get APLT Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-2 707

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

1.135

Debt / Equity ratio:

ROE:

-3 164

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

APLT analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for APLT to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Applied Therapeutics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Applied Therapeutics Inc dividends

APLT dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About APLT stock

About the company Applied Therapeutics Inc

Market cap $B

0.601

Dividend yield

Shares outstanding

48.059 B

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. The company is headquartered in New York City, New York and currently employs 34 full-time employees. The company went IPO on 2019-05-09. The Company’s molecular target is aldose reductase (AR), an enzyme that converts glucose to sorbitol under oxidative stress conditions. Its product candidates include AT-007, AT-001, AT-003 and AT-104. The Company’s AT-007 is a central nervous system (CNS) penetrant ARI, which is developed for the treatment of galactosemia. AT-001 is an aldose reductase inhibitor (ARI) with exposure and nerve permeability. AT-001 is developed for the treatment of diabetic cardiomyopathy (DbCM), fatal fibrosis of the heart. Its AT-003 is an ARI designed to cross through the back of the eye when dosed orally. AT-003 is developed for the treatment of diabetic retinopathy (DR). AT-104 is a dual selective PI3K inhibitor in preclinical development for T Cell Acute Lymphoblastic Leukemia (T-ALL).

APLT profile

  • Ticker

    APLT

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    09 May 2019

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    34

  • City

    New York City

  • Address

    545 5Th Avenue, Suite 1400

  • Cusip

    03828A101